Actinogen Medical has announced the appointment of Andrew Udell, a US-based executive, as its chief commercial officer, reporting to CEO Dr Steven Gourlay. Mr Udell has extensive commercial experience in bringing CNS drugs to market.
Company Information
Company
Actinogen Medical
Location
Sydney, New South Wales, Australia
About
Actinogen Medical is developing a novel therapy for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol. It is currently developing its lead compound, Xanamem, as a potential new therapy for Alzheimer’s disease and depression.
Fundz sees it the moment Actinogen Medical changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
SydneyBiotechnologyHealth CareMedicalTherapeutics